Related references
Note: Only part of the references are listed.Ovarian cancer microenvironment: implications for cancer dissemination and chemoresistance acquisition
Benoit Thibault et al.
CANCER AND METASTASIS REVIEWS (2014)
Autophagy Inhibition Augments the Anticancer Effects of Epirubicin Treatment in Anthracycline-Sensitive and -Resistant Triple-Negative Breast Cancer
Suganthi Chittaranjan et al.
CLINICAL CANCER RESEARCH (2014)
Fibroblasts Protect Melanoma Cells from the Cytotoxic Effects of Doxorubicin
Manoela Tiago et al.
TISSUE ENGINEERING PART A (2014)
Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma
Chiharu Tabata et al.
BMC CANCER (2013)
Stromal cells in tumor microenvironment and breast cancer
Yan Mao et al.
CANCER AND METASTASIS REVIEWS (2013)
High mobility group box 1 released from necrotic cells enhances regrowth and metastasis of cancer cells that have survived chemotherapy
Yi Luo et al.
EUROPEAN JOURNAL OF CANCER (2013)
Breast stromal fibroblasts from histologically normal surgical margins are pro-carcinogenic
Maha A. Al-Rakan et al.
JOURNAL OF PATHOLOGY (2013)
Adjuvant Systemic Therapies in Breast Cancer
Leonel F. Hernandez-Aya et al.
SURGICAL CLINICS OF NORTH AMERICA (2013)
Circulating immunogenic cell death biomarkers HMGB1 and RAGE in breast cancer patients during neoadjuvant chemotherapy
Oliver J. Stoetzer et al.
TUMOR BIOLOGY (2013)
The Role of Glycyrrhizin, an Inhibitor of HMGB1 Protein, in Anticancer Therapy
Ryszard Smolarczyk et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2012)
Cancer Cell Secretion of the DAMP Protein HMGB1 Supports Progression in Malignant Mesothelioma
Sandro Jube et al.
CANCER RESEARCH (2012)
The Tumor Stroma as Mediator of Drug Resistance - A Potential Target to Improve Cancer Therapy?
Susanne Sebens et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2012)
TNF-α induced secretion of HMGB1 from non-immune canine mammary epithelial cells (MTH53A)
Saskia Willenbrock et al.
CYTOKINE (2012)
High-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases
Wei Yan et al.
HEPATOLOGY (2012)
Epithelial-mesenchymal transition in breast cancer correlates with high histological grade and triple-negative phenotype
Hoiseon Jeong et al.
HISTOPATHOLOGY (2012)
Implication of Tumor Microenvironment in Chemoresistance: Tumor-Associated Stromal Cells Protect Tumor Cells from Cell Death
Magali Castells et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
HMGB1 is overexpressed in tumor cells and promotes activity of regulatory T cells in patients with head and neck cancer
Clarissa A. Wild et al.
ORAL ONCOLOGY (2012)
Diagnostic Significance of Serum HMGB1 in Colorectal Carcinomas
Hanna Lee et al.
PLOS ONE (2012)
DAMP-mediated autophagy contributes to drug resistance
Liying Liu et al.
AUTOPHAGY (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Anti-estrogen resistance in breast cancer is induced by the tumor microenvironment and can be overcome by inhibiting mitochondrial function in epithelial cancer cells
Ubaldo E. Martinez-Outschoorn et al.
CANCER BIOLOGY & THERAPY (2011)
HMGB-1 Induces IL-6 Production in Human Synovial Fibroblasts Through c-Src, Akt and NF-κB Pathways
Chun-Han Hou et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
DNA Alkylating Therapy Induces Tumor Regression through an HMGB1-Mediated Activation of Innate Immunity
Jennifer L. Guerriero et al.
JOURNAL OF IMMUNOLOGY (2011)
HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells
L. Liu et al.
LEUKEMIA (2011)
HMGB1 and RAGE in Inflammation and Cancer
Gary P. Sims et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Hmgb1 Promotes Wound Healing of 3T3 Mouse Fibroblasts via Rage-Dependent ERK1/2 Activation
Elia Ranzato et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2010)
Cancer associated fibroblasts (CAFs) in tumor microenvironment
Fei Xing et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2010)
The expression of HMGB1 protein and its receptor RAGE in human malignant tumors
Nora Kostova et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2010)
Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker
Kusumawadee Utispan et al.
MOLECULAR CANCER (2010)
Cancer associated fibroblasts in cancer pathogenesis
Omar E. Franco et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2010)
A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer
Pierre Farmer et al.
NATURE MEDICINE (2009)
Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype
David Sarrió et al.
CANCER RESEARCH (2008)
Role of myofibroblasts in innate chemoresistance of pancreatic carcinoma -: Epigenetic downregulation of caspases
Susanne Sebens Mueerkoester et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Increased expression of high mobility group box 1 (HMGB1) is associated with progression and poor prognosis in human nasopharyngeal carcinoma
D. Wu et al.
JOURNAL OF PATHOLOGY (2008)
Non-Hodgkin lymphoma expressing high levels of the danger-signalling protein HMGB1
Anke Meyer et al.
LEUKEMIA & LYMPHOMA (2008)
Upregulation of HMGA2 in thyroid carcinomas: a novel molecular marker to distinguish between benign and malignant follicular Neoplasias
Gazanfer Belge et al.
GENES CHROMOSOMES & CANCER (2008)
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
Lionel Apetoh et al.
NATURE MEDICINE (2007)
High mobility group box I (HMGB1) release from tumor cells after treatment: Implications for development of targeted chemoimmunotherapy
Xiang Da (Eric) Dong et al.
JOURNAL OF IMMUNOTHERAPY (2007)
Masquerader: High mobility group box-1 and cancer
Jessica E. Ellerman et al.
CLINICAL CANCER RESEARCH (2007)
Direct involvement of breast tumor fibroblasts in the modulation of tamoxifen sensitivity
Malathy P. V. Shekhar et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Cytolytic cells induce HMGB1 release from melanoma cell lines
Norimasa Ito et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake
Markus Loeffler et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Tumor stroma interactions induce chemoresistance in pancreatic ductal carcinoma cells involving increased secretion and paracrine effects of nitric oxide and in terleukin-1β
S Müerköster et al.
CANCER RESEARCH (2004)
Role of cancer-associated stromal fibroblasts in metastatic colon cancer to the liver and their expression profiles
H Nakagawa et al.
ONCOGENE (2004)
Molecular characterization of the tumor microenvironment in breast cancer
M Allinen et al.
CANCER CELL (2004)
Highly proliferative fibroblasts forming fibrotic focus govern metastasis of invasive ductal carcinoma of the breast
T Hasebe et al.
MODERN PATHOLOGY (2001)
Proliferative activity of intratumoral fibroblasts is closely correlated with lymph node and distant organ metastases of invasive ductal carcinoma of the breast
T Hasebe et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
